1. Market Research
  2. > Pharmaceutical Market Trends
  3. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Sweden

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: Sweden
SWEDEN.1
HEALTHCARE SYSTEM..1
Facts and Figures ..1
Market Indicators2
Provision and Funding ...4
PRICING...5
Prescription Drugs..5
Overview..5
TLV ..6
County Councils ..7
Pharmacy Discounts8
7.5% Price Cuts for Older Drugs .8
Generic Drugs 9
Ceiling Prices...9
7.5% Price Cuts for Older Drugs .9
Hospital Drugs9
TLV ..9
County Councils 10
OTC Drugs ...10
REIMBURSEMENT 10
Admission to Reimbursement ..10
TLV 11
County Councils 13
Reimbursement Categories .13
Reimbursement Prices.14
Hospital Reimbursement..14
Health Economic Assessments of Hospital Drugs 14
Formularies15
Funding..15
Changes in Reimbursement Status .15
Reassessment Process.16
Recent Reassessments.16
Abandoned Reassessments..16
Ongoing Reassessments ..17
Products with Restricted or Conditional Reimbursement Approval...17
Changes in Reimbursement Prices .18
Patented Drugs..18
Off-patent Drugs 19
New Dosage Forms, Pack Sizes and Strengths ...20
PHARMACOECONOMICS.20
Pharmacoeconomic Requirements..20
Guidelines..20
Evaluation..21
Hospital Drugs ...21
PRICE BUILD UP ...21
Wholesalers .21
Margins ..21
Background21
Retail Pharmacies 22
Margins ..22
Review of Pharmacy Margins23
Background23
Pharmacy Market Review..25
E-pharmacy ...25
Multi-dose Dispensing ...25
Dispensing Doctors ..26
Sales Tax .26
COST CONTAINMENT ..26
Industry Paybacks26
Promotional Costs26
Patient Co-payments26
Pharmaceuticals 26
Healthcare .27
Prescribing Controls.28
Funding Agreement ...28
Prescribing Budgets ..29
Drug Committees...29
NT Council.29
National Guidelines ...30
E-prescriptions...30
Generics...30
Generic Substitution ..30
INN Prescribing .33
Rx-to-OTC Switches 33
Switching Process .33
Liberalised OTC Sales...33
OTC Market ...33
Parallel Trade...34
Parallel Import Market ...34
Pricing Regulations34
Price Discounts..34
Parallel Import Substitution34
FUTURE DEVELOPMENTS ..35
Outlook.35
Review of Drug Financing, Pricing and Reimbursement...35
Review of the Processes for Introducing New Drugs 35
Other Developments..36
NAMES and ADDRESSES 37

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025 Summary Sales of dyslipidemia therapeutics is estimated to be approximately $11.2B across the 7MM in 2015, encompassing the ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.